In a mouse xenograft study, we demonstrated that the CysLT1R antagonist treatment reduces the colon cancer tumor growth by impairing angiogenesis, inducing apoptosis and inhibiting proliferation [21]. The gene discussed is CYSLTR1; the disease is colonic neoplasm.